Choreo LLC increases its position in Colgate-Palmolive (NYSE:CL)

Choreo LLC raised its stake in Colgate-Palmolive (NYSE:CL – Free Report ) by 200.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,489 shares of the company’s stock after buying an additional 15,013 shares during the period. Choreo LLC’s holdings in Colgate-Palmolive were worth $2,153,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in CL. Gryphon Financial Partners LLC purchased a new position in Colgate-Palmolive in the 4th quarter worth about $225,000. Principal Securities Inc. acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at $366,000. QRG Capital Management Inc. lifted its position in Colgate-Palmolive by 5.8% in the fourth quarter. QRG Capital Management Inc. now owns 46,633 shares of the company’s stock valued at $3,717,000 after buying an additional 2,540 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Colgate-Palmolive by 1.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,793,195 shares of the company’s stock valued at $222,637,000 after buying an additional 30,979 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its position in Colgate-Palmolive by 16.1% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 18,637 shares of the company’s stock worth $1,486,000 after buying an additional 2,582 shares during the period. 80.41% of the shares are currently owned by institutional investors and hedge funds.

Changes in Analyst Ratings

A number of analysts recently commented on CL shares. BNP Paribas assumed coverage on Colgate-Palmolive in a research note on Monday, June 24th. They issued an “outperform” rating and a $109.00 target price on the stock. Morgan Stanley boosted their price objective on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $92.00 to $97.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 10th. Sanford C. Bernstein upped their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. Finally, Hsbc Global Res downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Nine investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average price target of $102.63, according to MarketBeat .

Check out our latest report on Colgate-Palmolive

Indoor activity

In other Colgate-Palmolive news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the transaction, the executive vice president now directly owns 10,377 shares of the company’s stock, valued at $1,069,868.70. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available on the SEC’s website. In other Colgate-Palmolive news, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the sale, the executive vice president now owns 10,377 shares of the company’s stock, valued at $1,069,868.70. The transaction was disclosed in a legal filing with the SEC, which is available via this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,490 shares of company stock worth $4,486,063. 0.34% of shares are currently owned by insiders.

Colgate-Palmolive stock performance

CL opened at $106.84 on Wednesday. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $109.30. The firm has a market cap of $87.30 billion, a PE ratio of 33.81, a PEG ratio of 3.78 and a beta of 0.40. The company has a current ratio of 1.06, a quick ratio of 0.70, and a debt-to-equity ratio of 16.90. The company’s 50-day moving average price is $101.52 and its 200-day moving average price is $94.88.

Colgate-Palmolive (NYSE:CL – Get Your Free Report ) last released its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The company had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. During the same period in the previous year, the firm posted EPS of $0.77. The company’s revenue for the quarter was up 4.9% compared to the same quarter last year. As a group, sell-side analysts expect Colgate-Palmolive to post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, July 19. This represents an annualized dividend of $2.00 and a dividend yield of 1.87%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Colgate-Palmolive profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, personal and home care; and Pet Nutrition. The oral, personal and home care segment offers toothpaste, toothbrushes, mouthwash, hand soaps and liquids, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners and other related items.

Featured stories

Get news and reviews for Colgate-Palmolive Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.